Research Summary
A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.
According to WENKH research statistics, the global Pharmaceutical CDMO market size will reach 172,804 Million USD in 2025 and is projected to reach 286,131 Million USD by 2032, with a CAGR of 7.47% (2025-2032). Among them, the Asia-Pacific Pharmaceutical CDMO market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.
The role of CDMOs in the global pharmaceutical ecosystem is becoming more strategic than ever, as drug developers increasingly outsource not just manufacturing, but also R&D, formulation design, and regulatory support. The push toward leaner operations and faster time-to-market has made CDMOs valuable partners in both early-stage development and late-phase commercialization. Companies are no longer looking for just capacity—they want technical agility, quality consistency, and innovation alignment. CDMOs that specialize in high-barrier technologies such as biologics, mRNA, and sterile injectables are gaining a competitive edge, especially as the pipeline of complex, niche therapies grows.
The application prospects for CDMO products are expanding in line with shifts in the global drug innovation landscape. Small and mid-sized biotech firms, often operating with limited internal infrastructure, are relying on CDMOs for integrated solutions—from process development to clinical trial material supply and commercial batch production. The rise of personalized medicine and precision therapies is further shaping demand for flexible, small-batch manufacturing capabilities. CDMOs that can scale quickly without compromising quality or regulatory compliance are becoming essential enablers of product launch success, particularly in fast-moving fields like oncology, rare diseases, and gene therapy. Global macro trends are also redefining how CDMO services are used. Governments are investing in localized production for national health security, while pharma companies are seeking supply chain redundancy after disruptions seen during the COVID-19 pandemic. This makes CDMOs with multi-region manufacturing footprints and digitalized operations increasingly attractive.
The global Pharmaceutical CDMO market is highly competitive, with key market players including Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, Pfizer CentreOne, Delpharm, Recipharm, AGC Pharma Chemicals, Boehringer Ingelheim, Vetter, Curia, Aenova, Porton, Piramal, Strides Pharma, NextPharma, Famar, Jubilant, Alcami, Euroapi, Eurofins, Avid Bioservices, BioVectra, CPL, etc. This report categorizes the competitive landscape of the global Pharmaceutical CDMO market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Pharmaceutical CDMO market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Pharmaceutical CDMO industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Pharmaceutical CDMO and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2020 to 2024, providing a solid foundation for analyzing past market trends. The year 2025 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2026 to 2032, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Pharmaceutical CDMO in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Pharmaceutical CDMO market. By considering local policies, this report evaluates the market prospects of Pharmaceutical CDMO in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Piramal
Strides Pharma
NextPharma
Famar
Jubilant
Alcami
Euroapi
Eurofins
Avid Bioservices
BioVectra
CPL
Product Segment
API CDMO
FDF CDMO
Packaging CDMO
Clinical CDMO
Product Application
Chemical Pharmaceutical
Biopharmaceutical
Others
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Pharmaceutical CDMO Industry Chain Analysis
Chapter 3: Global Pharmaceutical CDMO Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Pharmaceutical CDMO Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Pharmaceutical CDMO Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Pharmaceutical CDMO Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Pharmaceutical CDMO Market Overview
1.1 Product Definition Introduction
1.2 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis (2020-2032)
1.3 Pharmaceutical CDMO Market Status and Development Prospects
1.3.1 Pharmaceutical CDMO Market Status
1.3.2 Pharmaceutical CDMO Industry Development Prospects
1.4 Pharmaceutical CDMO Market Overview by Product Segment
1.4.1 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032
1.4.2 API CDMO
1.4.3 FDF CDMO
1.4.4 Packaging CDMO
1.4.5 Clinical CDMO
1.5 Pharmaceutical CDMO Market Overview by Product Application
1.5.1 Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032
1.5.2 Chemical Pharmaceutical
1.5.3 Biopharmaceutical
1.5.4 Others
2 Pharmaceutical CDMO Industry Supply Chain Analysis
2.1 Pharmaceutical CDMO Supply Chain
2.2 Pharmaceutical CDMO Midstream Suppliers
2.3 Pharmaceutical CDMO Downstream Customers
2.4 Pharmaceutical CDMO Sales Channel Analysis
3 Pharmaceutical CDMO Market Environment Analysis
3.1 Pharmaceutical CDMO Industry Policy Analysis
3.2 Pharmaceutical CDMO Emerging Technology Trends in the Industry
3.3 Pharmaceutical CDMO Restraining Factors Analysis
3.4 Pharmaceutical CDMO Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Pharmaceutical CDMO Market Players Competition Landscape
4.1 Global Pharmaceutical CDMO Market Revenue by Key Players (2021-2025)
4.2 Global Pharmaceutical CDMO Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Pharmaceutical CDMO Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Lonza
5.1.1 Lonza Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Lonza Pharmaceutical CDMO Product Features
5.1.3 Lonza Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.2 Catalent
5.2.1 Catalent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Catalent Pharmaceutical CDMO Product Features
5.2.3 Catalent Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Thermo Fisher Scientific Pharmaceutical CDMO Product Features
5.3.3 Thermo Fisher Scientific Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.4 Samsung Biologics
5.4.1 Samsung Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Samsung Biologics Pharmaceutical CDMO Product Features
5.4.3 Samsung Biologics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.5 Fareva
5.5.1 Fareva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 Fareva Pharmaceutical CDMO Product Features
5.5.3 Fareva Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.6 WuXi AppTech
5.6.1 WuXi AppTech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 WuXi AppTech Pharmaceutical CDMO Product Features
5.6.3 WuXi AppTech Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.7 WuXi Biologics
5.7.1 WuXi Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 WuXi Biologics Pharmaceutical CDMO Product Features
5.7.3 WuXi Biologics Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.8 Siegfried
5.8.1 Siegfried Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Siegfried Pharmaceutical CDMO Product Features
5.8.3 Siegfried Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.9 FUJIFILM Diosynth Biotechnologies
5.9.1 FUJIFILM Diosynth Biotechnologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Features
5.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.10 Asymchem
5.10.1 Asymchem Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Asymchem Pharmaceutical CDMO Product Features
5.10.3 Asymchem Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.11 Pfizer CentreOne
5.11.1 Pfizer CentreOne Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Pfizer CentreOne Pharmaceutical CDMO Product Features
5.11.3 Pfizer CentreOne Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.12 Delpharm
5.12.1 Delpharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 Delpharm Pharmaceutical CDMO Product Features
5.12.3 Delpharm Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.13 Recipharm
5.13.1 Recipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 Recipharm Pharmaceutical CDMO Product Features
5.13.3 Recipharm Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.14 AGC Pharma Chemicals
5.14.1 AGC Pharma Chemicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.14.2 AGC Pharma Chemicals Pharmaceutical CDMO Product Features
5.14.3 AGC Pharma Chemicals Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.15 Boehringer Ingelheim
5.15.1 Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.15.2 Boehringer Ingelheim Pharmaceutical CDMO Product Features
5.15.3 Boehringer Ingelheim Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.16 Vetter
5.16.1 Vetter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.16.2 Vetter Pharmaceutical CDMO Product Features
5.16.3 Vetter Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.17 Curia
5.17.1 Curia Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.17.2 Curia Pharmaceutical CDMO Product Features
5.17.3 Curia Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.18 Aenova
5.18.1 Aenova Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.18.2 Aenova Pharmaceutical CDMO Product Features
5.18.3 Aenova Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.19 Porton
5.19.1 Porton Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.19.2 Porton Pharmaceutical CDMO Product Features
5.19.3 Porton Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.20 Piramal
5.20.1 Piramal Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.20.2 Piramal Pharmaceutical CDMO Product Features
5.20.3 Piramal Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.21 Strides Pharma
5.21.1 Strides Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.21.2 Strides Pharma Pharmaceutical CDMO Product Features
5.21.3 Strides Pharma Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.22 NextPharma
5.22.1 NextPharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.22.2 NextPharma Pharmaceutical CDMO Product Features
5.22.3 NextPharma Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.23 Famar
5.23.1 Famar Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.23.2 Famar Pharmaceutical CDMO Product Features
5.23.3 Famar Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.24 Jubilant
5.24.1 Jubilant Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.24.2 Jubilant Pharmaceutical CDMO Product Features
5.24.3 Jubilant Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.25 Alcami
5.25.1 Alcami Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.25.2 Alcami Pharmaceutical CDMO Product Features
5.25.3 Alcami Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.26 Euroapi
5.26.1 Euroapi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.26.2 Euroapi Pharmaceutical CDMO Product Features
5.26.3 Euroapi Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.27 Eurofins
5.27.1 Eurofins Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.27.2 Eurofins Pharmaceutical CDMO Product Features
5.27.3 Eurofins Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.28 Avid Bioservices
5.28.1 Avid Bioservices Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.28.2 Avid Bioservices Pharmaceutical CDMO Product Features
5.28.3 Avid Bioservices Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.29 BioVectra
5.29.1 BioVectra Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.29.2 BioVectra Pharmaceutical CDMO Product Features
5.29.3 BioVectra Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
5.30 CPL
5.30.1 CPL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.30.2 CPL Pharmaceutical CDMO Product Features
5.30.3 CPL Pharmaceutical CDMO Product Revenue and Gross Margin Analysis (2021-2025)
6 Global Pharmaceutical CDMO Market Analysis by Countries, by Product Segment and Application
6.1 Global Pharmaceutical CDMO Market Size and Growth Forecast by Countries: 2020 VS 2025 VS 2032
6.1.1 Global Pharmaceutical CDMO Market Revenue by Countries (2020-2025)
6.1.2 Global Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032)
6.2 Global Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
6.3 Global Pharmaceutical CDMO Market Size by Product Application (2020-2032)
7 United States Pharmaceutical CDMO Market Analysis
7.1 United States Pharmaceutical CDMO Market Prospects
7.2 United States Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
7.3 United States Pharmaceutical CDMO Market Size by Product Application (2020-2032)
8 China Pharmaceutical CDMO Market Analysis
8.1 China Pharmaceutical CDMO Market Prospects
8.2 China Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
8.3 China Pharmaceutical CDMO Market Size by Product Application (2020-2032)
9 Germany Pharmaceutical CDMO Market Analysis
9.1 Germany Pharmaceutical CDMO Market Prospects
9.2 Germany Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
9.3 Germany Pharmaceutical CDMO Market Size by Product Application (2020-2032)
10 Japan Pharmaceutical CDMO Market Analysis
10.1 Japan Pharmaceutical CDMO Market Prospects
10.2 Japan Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
10.3 Japan Pharmaceutical CDMO Market Size by Product Application (2020-2032)
11 France Pharmaceutical CDMO Market Analysis
11.1 France Pharmaceutical CDMO Market Prospects
11.2 France Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
11.3 France Pharmaceutical CDMO Market Size by Product Application (2020-2032)
12 South Korea Pharmaceutical CDMO Market Analysis
12.1 South Korea Pharmaceutical CDMO Market Prospects
12.2 South Korea Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
12.3 South Korea Pharmaceutical CDMO Market Size by Product Application (2020-2032)
13 United Kingdom Pharmaceutical CDMO Market Analysis
13.1 United Kingdom Pharmaceutical CDMO Market Prospects
13.2 United Kingdom Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
13.3 United Kingdom Pharmaceutical CDMO Market Size by Product Application (2020-2032)
14 India Pharmaceutical CDMO Market Analysis
14.1 India Pharmaceutical CDMO Market Prospects
14.2 India Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
14.3 India Pharmaceutical CDMO Market Size by Product Application (2020-2032)
15 Italy Pharmaceutical CDMO Market Analysis
15.1 Italy Pharmaceutical CDMO Market Prospects
15.2 Italy Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
15.3 Italy Pharmaceutical CDMO Market Size by Product Application (2020-2032)
16 Brazil Pharmaceutical CDMO Market Analysis
16.1 Brazil Pharmaceutical CDMO Market Prospects
16.2 Brazil Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
16.3 Brazil Pharmaceutical CDMO Market Size by Product Application (2020-2032)
17 Mexico Pharmaceutical CDMO Market Analysis
17.1 Mexico Pharmaceutical CDMO Market Prospects
17.2 Mexico Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
17.3 Mexico Pharmaceutical CDMO Market Size by Product Application (2020-2032)
18 Indonesia Pharmaceutical CDMO Market Analysis
18.1 Indonesia Pharmaceutical CDMO Market Prospects
18.2 Indonesia Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
18.3 Indonesia Pharmaceutical CDMO Market Size by Product Application (2020-2032)
19 Vietnam Pharmaceutical CDMO Market Analysis
19.1 Vietnam Pharmaceutical CDMO Market Prospects
19.2 Vietnam Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
19.3 Vietnam Pharmaceutical CDMO Market Size by Product Application (2020-2032)
20 South Africa Pharmaceutical CDMO Market Analysis
20.1 South Africa Pharmaceutical CDMO Market Prospects
20.2 South Africa Pharmaceutical CDMO Market Size by Product Segment (2020-2032)
20.3 South Africa Pharmaceutical CDMO Market Size by Product Application (2020-2032)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Segment (2020 VS 2025 VS 2032) & (Million USD)
Table 2：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis by Product Application (2020 VS 2025 VS 2032) & (Million USD)
Table 3：Pharmaceutical CDMO Downstream Customers List
Table 4：Pharmaceutical CDMO Distributors/Dealers List
Table 5：Global Pharmaceutical CDMO Market Revenue by Key Players (2021-2025) & (Million USD)
Table 6：Global Pharmaceutical CDMO Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Pharmaceutical CDMO Market Expansion and M&A Dynamic
Table 9：Lonza Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Lonza Pharmaceutical CDMO Product Features
Table 11：Lonza Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 12：Catalent Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：Catalent Pharmaceutical CDMO Product Features
Table 14：Catalent Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 15：Thermo Fisher Scientific Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：Thermo Fisher Scientific Pharmaceutical CDMO Product Features
Table 17：Thermo Fisher Scientific Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 18：Samsung Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Samsung Biologics Pharmaceutical CDMO Product Features
Table 20：Samsung Biologics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 21：Fareva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：Fareva Pharmaceutical CDMO Product Features
Table 23：Fareva Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 24：WuXi AppTech Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：WuXi AppTech Pharmaceutical CDMO Product Features
Table 26：WuXi AppTech Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 27：WuXi Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：WuXi Biologics Pharmaceutical CDMO Product Features
Table 29：WuXi Biologics Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 30：Siegfried Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：Siegfried Pharmaceutical CDMO Product Features
Table 32：Siegfried Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 33：FUJIFILM Diosynth Biotechnologies Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Product Features
Table 35：FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 36：Asymchem Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Asymchem Pharmaceutical CDMO Product Features
Table 38：Asymchem Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 39：Pfizer CentreOne Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Pfizer CentreOne Pharmaceutical CDMO Product Features
Table 41：Pfizer CentreOne Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 42：Delpharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 43：Delpharm Pharmaceutical CDMO Product Features
Table 44：Delpharm Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 45：Recipharm Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 46：Recipharm Pharmaceutical CDMO Product Features
Table 47：Recipharm Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 48：AGC Pharma Chemicals Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 49：AGC Pharma Chemicals Pharmaceutical CDMO Product Features
Table 50：AGC Pharma Chemicals Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 51：Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 52：Boehringer Ingelheim Pharmaceutical CDMO Product Features
Table 53：Boehringer Ingelheim Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 54：Vetter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Vetter Pharmaceutical CDMO Product Features
Table 56：Vetter Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 57：Curia Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 58：Curia Pharmaceutical CDMO Product Features
Table 59：Curia Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 60：Aenova Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 61：Aenova Pharmaceutical CDMO Product Features
Table 62：Aenova Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 63：Porton Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 64：Porton Pharmaceutical CDMO Product Features
Table 65：Porton Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 66：Piramal Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 67：Piramal Pharmaceutical CDMO Product Features
Table 68：Piramal Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 69：Strides Pharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 70：Strides Pharma Pharmaceutical CDMO Product Features
Table 71：Strides Pharma Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 72：NextPharma Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 73：NextPharma Pharmaceutical CDMO Product Features
Table 74：NextPharma Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 75：Famar Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 76：Famar Pharmaceutical CDMO Product Features
Table 77：Famar Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 78：Jubilant Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 79：Jubilant Pharmaceutical CDMO Product Features
Table 80：Jubilant Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 81：Alcami Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 82：Alcami Pharmaceutical CDMO Product Features
Table 83：Alcami Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 84：Euroapi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 85：Euroapi Pharmaceutical CDMO Product Features
Table 86：Euroapi Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 87：Eurofins Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 88：Eurofins Pharmaceutical CDMO Product Features
Table 89：Eurofins Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 90：Avid Bioservices Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 91：Avid Bioservices Pharmaceutical CDMO Product Features
Table 92：Avid Bioservices Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 93：BioVectra Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 94：BioVectra Pharmaceutical CDMO Product Features
Table 95：BioVectra Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 96：CPL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 97：CPL Pharmaceutical CDMO Product Features
Table 98：CPL Pharmaceutical CDMO Revenue (Million USD) and Gross Margin (2021-2025)
Table 99：Global Pharmaceutical CDMO Market Size and Growth Forecast by Countries (2020 VS 2025 VS 2032) & (Million USD)
Table 100：Global Pharmaceutical CDMO Market Revenue by Countries (2020-2025) & (Million USD)
Table 101：Global Pharmaceutical CDMO Market Share by Countries (2020-2025)
Table 102：Global Pharmaceutical CDMO Market Revenue Forecast by Countries (2026-2032) & (Million USD)
Table 103：Global Pharmaceutical CDMO Market Share Forecast by Countries (2026-2032)
Table 104：Global Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 105：Global Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 106：Global Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 107：Global Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 108：United States Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 109：United States Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 110：United States Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 111：United States Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 112：China Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 113：China Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 114：China Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 115：China Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 116：Germany Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 117：Germany Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 118：Germany Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 119：Germany Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 120：Japan Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 121：Japan Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 122：Japan Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 123：Japan Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 124：France Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 125：France Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 126：France Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 127：France Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 128：South Korea Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 129：South Korea Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 130：South Korea Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 131：South Korea Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 132：United Kingdom Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 133：United Kingdom Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 134：United Kingdom Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 135：United Kingdom Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 136：India Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 137：India Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 138：India Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 139：India Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 140：Italy Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 141：Italy Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 142：Italy Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 143：Italy Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 144：Brazil Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 145：Brazil Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 146：Brazil Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 147：Brazil Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 148：Mexico Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 149：Mexico Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 150：Mexico Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 151：Mexico Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 152：Indonesia Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 153：Indonesia Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 154：Indonesia Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 155：Indonesia Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 156：Vietnam Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 157：Vietnam Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 158：Vietnam Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 159：Vietnam Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 160：South Africa Pharmaceutical CDMO Market Revenue by Product Segment (2020-2025) & (Million USD)
Table 161：South Africa Pharmaceutical CDMO Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)
Table 162：South Africa Pharmaceutical CDMO Market Revenue by Product Application (2020-2025) & (Million USD)
Table 163：South Africa Pharmaceutical CDMO Market Revenue Forecast by Product Application (2026-2032) & (Million USD)
Table 164：Secondary Sources
Figure 1：Pharmaceutical CDMO Product Scope
Figure 2：Global Pharmaceutical CDMO Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)
Figure 3：Global Pharmaceutical CDMO Product Segment Market Share (2025 & 2032)
Figure 4：Global Pharmaceutical CDMO Product Application Market Share (2025 & 2032)
Figure 5：API CDMO Product Scope
Figure 6：FDF CDMO Product Scope
Figure 7：Packaging CDMO Product Scope
Figure 8：Clinical CDMO Product Scope
Figure 9：Chemical Pharmaceutical Product Scope
Figure 10：Biopharmaceutical Product Scope
Figure 11：Others Product Scope
Figure 12：Pharmaceutical CDMO Industrial Chain Framework
Figure 13：Global Pharmaceutical CDMO Market by Geographic Segmentation in 2025
Figure 14：Global Pharmaceutical CDMO Market Share by Countries (2020 VS 2025)
Figure 15：United States Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 16：China Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 17：Germany Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 18：Japan Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 19：France Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 20：South Korea Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 21：United Kingdom Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 22：India Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 23：Italy Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 24：Brazil Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 25：Mexico Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 26：Indonesia Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 27：Vietnam Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 28：South Africa Pharmaceutical CDMO Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)
Figure 29：Research Methodology
Figure 30：Primary Sources
Figure 31：Data Cross Validation
Global Pharmaceutical CDMO Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Lonza | XX | XX | XX | XX | XX |
| Catalent | XX | XX | XX | XX | XX |
| Thermo Fisher Scientific | XX | XX | XX | XX | XX |
| Samsung Biologics | XX | XX | XX | XX | XX |
| Fareva | XX | XX | XX | XX | XX |
| WuXi AppTech | XX | XX | XX | XX | XX |
| WuXi Biologics | XX | XX | XX | XX | XX |
| Siegfried | XX | XX | XX | XX | XX |
| FUJIFILM Diosynth Biotechnologies | XX | XX | XX | XX | XX |
| Asymchem | XX | XX | XX | XX | XX |
| Pfizer CentreOne | XX | XX | XX | XX | XX |
| Delpharm | XX | XX | XX | XX | XX |
| Recipharm | XX | XX | XX | XX | XX |
| AGC Pharma Chemicals | XX | XX | XX | XX | XX |
| Boehringer Ingelheim | XX | XX | XX | XX | XX |
| Vetter | XX | XX | XX | XX | XX |
| Curia | XX | XX | XX | XX | XX |
| Aenova | XX | XX | XX | XX | XX |
| Porton | XX | XX | XX | XX | XX |
| Piramal | XX | XX | XX | XX | XX |
| Strides Pharma | XX | XX | XX | XX | XX |
| NextPharma | XX | XX | XX | XX | XX |
| Famar | XX | XX | XX | XX | XX |
| Jubilant | XX | XX | XX | XX | XX |
| Alcami | XX | XX | XX | XX | XX |
| Euroapi | XX | XX | XX | XX | XX |
| Eurofins | XX | XX | XX | XX | XX |
| Avid Bioservices | XX | XX | XX | XX | XX |
| BioVectra | XX | XX | XX | XX | XX |
| CPL | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
